RE: A bitter battle?17 May 2021 10:10
Do not think they are concerned with employees, they are looking at maximising their own returns, look at her pay packet over the last few years. That is what troubles me the SP has under performed but yet her bank balance has done really well, also not shy to be a member of other companies boards.
Think she should be allowed to see through her strategy as this is not entirely her fault, started years ago and she has not been able to fully execute it yet. But that aside she has been with the company more than 10 years, largely running the Consumer Healthcare , she is not the right person to run the vaccine and pharma business that is apparent.
The costly acquisitions has been a catch up due to her predecessors not matching others on research and getting rid of the oncology business.
Don't think the dividend needs to be cut by much, but we really need to see the pipeline grow. Good recent new on the Covid vaccines news, we can be a big player in the years to come, blessing in disguise with the issues dogging Astra now with Europe. Who have done an an immaculate job getting something out there by the way.